This website uses cookies and similar technologies (hereinafter collectively referred to as ‘cookies’). We may use cookies for the following purposes:
With the buttons below, you can choose which cookies you wish to accept. On our cookie statement page, you can manage your cookie preferences. You can always withdraw your consent for cookies by making different choices there. For more information about cookies, please refer to our cookie statement.
Xencor Inc has appointed RSM MSCBA alumnus Bart Cornelissen as chief financial officer to support its clinical-stage pipeline of engineered antibodies for the treatment of cancer and other serious diseases.
Read the report: https://www.mednous.com/appointment/new-cfo-xencor